Ongoing clinical trials for patients with RMC and RCCU-MP:
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma